Prostatic in Medical News
Navigation Links
Prostatic in Medical News
... than eight percent in the drug market for benign prostatic hyperplasia and male lower urinary tract symptoms ...
The new Pharmacor report entitled Benign prostatic Hyperplasia and Male Lower Urinary Tract Symptoms ... over half of all major-market sales for benign prostatic hyperplasia. Tamsulosin, the most widely-used ...
... Baseball(TM) to raise awareness of Benign prostatic Hyperplasia (BPH), a condition affecting more ... program in the U.S. to raise awareness of Benign prostatic Hyperplasia (BPH), commonly known as enlarged ... U is supported by sanofi-aventis. About Benign prostatic Hyperplasia (BPH) BPH is defined as a ...
... Paris. Enlarged prostate (also known as benign prostatic hyperplasia or BPH) is a progressive disease that ... on the Clinical Progression of Benign prostatic Hyperplasia. N Engl J Med 2003 Dec; ... Urinary Tract Symptoms in Men with Benign prostatic Hyperplasia ...
... 23% decline in sales of therapies to treat benign prostatic hyperplasia over the next five years. The new Pharmacor report entitled Benign prostatic Hyperplasia finds that the market to treat the ... create a favorable landscape for novel benign prostatic hyperplasia treatments. "Eli Lilly's Cialis and ...
... provides superior outcomes and long term durability in treating Benign prostatic Hyperplasia (BPH) of all gland sizes(2). There has been increasing ... system, the first holmium laser cleared by the FDA for treatment of Benign prostatic Hyperplasia (BPH), is also effective for surgical removal of stones, ...
... journals and discussion of the studies with regulatory agencies. Benign prostatic Hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men - ...
... a synthetic luteinizing hormone releasing hormone (LHRH) agonist, triptorelin, which suppresses the production of testosterone in the testicles. prostatic cancer proliferation is regulated in part by the level and activity of testosterone. TRELSTAR(R) is currently available in a four-week depot ...
... detection (colon cancer), a medication (the use of statins for treatment of elevated cholesterol) and a surgical procedure (treatment for benign prostatic hyperplasia). "The results of our study demonstrate that, while the lessons from the other countries' approaches to comparative effectiveness ...
... GELNIQUE, Watson recently launched RAPAFLO (TM) (silodosin), the Company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), which offers rapid relief and has an exceptional safety profile. The Company also has submitted a New Drug Application for its ...
... detection (colon cancer), a medication (the use of statins for treatment of elevated cholesterol) and a surgical procedure (treatment for benign prostatic hyperplasia). "The results of our study demonstrate that, while the lessons from the other countries' approaches to comparative effectiveness ...
... the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available ...
... in a Phase 3 trial for metastatic colorectal cancer (MCRC). LSO has also completed a Phase 1/2 trial and has initiated a Phase 2a trial in benign prostatic hyperplasia (BPH), or enlargement of the prostate, and has clinical or preclinical programs in cardiovascular disease, eye disease, ...
... candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. ...
... UEBW (ultrasound-estimated bladder weight) and bladder volume quickly and noninvasively to help diagnose bladder dysfunction, including BPH (benign prostatic hypertrophy) and BOO (bladder outlet obstruction). This new addition to the BladderScan(R) BVI 9000 series made its official debut at the AUA 2009 ...
AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM) Prostatic Stent
... devices for the management and treatment of prostatic obstruction, announced today that it has received ... to their flagship product, The Spanner(TM) prostatic Stent. "These changes are aimed at further ... of the device." The Spanner is a temporary prostatic stent designed to aid men who are experiencing ...... Baseball(TM) to raise awareness of Benign prostatic Hyperplasia (BPH), a condition affecting more ... program in the U.S. to raise awareness of Benign prostatic Hyperplasia (BPH), commonly known as enlarged ... U is supported by sanofi-aventis. About Benign prostatic Hyperplasia (BPH) BPH is defined as a ...
Invasive methods unnecessary for prostate cancer radiation therapy treatment planning
... (CT) is an effective method for locating the prostatic apex for radiation therapy treatment planning in ... if knowledge of the anatomic relationships of the prostatic base and the prostatic apex along with modern 3-D CT planning, could be ...Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
... provides superior outcomes in treating Benign prostatic Hyperplasia (BPH) of all gland sizes(1). ... laser cleared by the FDA for treatment of Benign prostatic Hyperplasia (BPH), is also effective for surgical ... in Urology, Holmium laser treatment of benign prostatic hyperplaisa: an update (2) 2008, Peter J. ...... Paris. Enlarged prostate (also known as benign prostatic hyperplasia or BPH) is a progressive disease that ... on the Clinical Progression of Benign prostatic Hyperplasia. N Engl J Med 2003 Dec; ... Urinary Tract Symptoms in Men with Benign prostatic Hyperplasia ...
... 23% decline in sales of therapies to treat benign prostatic hyperplasia over the next five years. The new Pharmacor report entitled Benign prostatic Hyperplasia finds that the market to treat the ... create a favorable landscape for novel benign prostatic hyperplasia treatments. "Eli Lilly's Cialis and ...
Vitamin E, Selenium and Soy Won't Prevent Prostate Cancer
... For the study, Fleshner's team randomly assigned 303 men with high-grade prostatic intraepithelial neoplasia (precancerous lesions) to receive soy protein, ... found. "To recommend soy and these supplement to men with high-grade prostatic intraepithelial neoplasia really doesn't make much sense, if the reason ...Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction
... -- Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonio and ... bladder outlet obstruction index in men with signs and symptoms of benign prostatic hyperplasia treated with tadalafil. J Urol, suppl. 2009: 181, 4, abstract ...Major statin study reveals several important findings for reducing prostate cancer and disease
... May Prevent Prostate Enlargement (April 28, 1:00-3:00 p.m. CDT) Benign prostatic enlargement affects one in four men ages 40 to 50 and almost half of 70- ... researchers have found that taking statins may prevent or delay benign prostatic enlargement. Of the 2,447 men studied, 729 (30 percent) were statin ...... provides superior outcomes and long term durability in treating Benign prostatic Hyperplasia (BPH) of all gland sizes(2). There has been increasing ... system, the first holmium laser cleared by the FDA for treatment of Benign prostatic Hyperplasia (BPH), is also effective for surgical removal of stones, ...
EAU TV goes 'live' at 24th Annual EAU Congress in Stockholm
... prostate cancer, bladder and testicular cancer, renal cell cancer, benign prostatic hyperplasia, robotics, urinary incontinence and andrology. The ... (DE) and Francesco Montorsi, Milan (IT). Male LUTS and Benign prostatic Obstruction Paul Abrams, Bristol (GB), Dr. Alexander Bachmann, Basel ...Enlarged prostates: The choice of treatment needs careful consideration
... time the cause is an enlarged prostate, a condition doctors call "benign prostatic hyperplasia". One in five men in their 50s are affected - and the majority ... blockers have taken over as the most common treatment choice for benign prostatic hyperplasia," said Professor Sawicki. "These drugs were originally ...... journals and discussion of the studies with regulatory agencies. Benign prostatic Hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men - ...
Severe Urinary Problems Boost Death Risk in Older Men
... is a medical emergency. The condition is often a progression of benign prostatic hyperplasia, an enlargement of the prostate that can interfere with normal ... spontaneous AUR (no evidence of precipitating factors other than benign prostatic hyperplasia), and one in four with precipitated AUR, died within one year. ...Study reveals high death toll after severe urinary complications in men over 45
... is the sudden inability to pass urine and is often a progression of benign prostatic hyperplasia (an increase in size of the prostate in middle-aged and ... spontaneous AUR (no evidence of precipitating factors other than benign prostatic hyperplasia) and one in four with precipitated AUR died in the first year. ...... a synthetic luteinizing hormone releasing hormone (LHRH) agonist, triptorelin, which suppresses the production of testosterone in the testicles. prostatic cancer proliferation is regulated in part by the level and activity of testosterone. TRELSTAR(R) is currently available in a four-week depot ...
AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
... offered by the Foundation. William Roberts, MD, earned the Astellas Rising Stars in Urology Award for his project titled, "Histotripsy for Benign prostatic Hyperplasia." His mentors at the University of Michigan are J. Brian Fowlkes, PhD and Charles Cain, PhD. Edward Schaeffer, MD, was named an ...Painkillers May Be Good for the Prostate
... anti-inflammatory drugs (NSAIDs) daily had a reduction of about 50 percent in enlargement of the prostate gland. The condition, called benign prostatic hyperplasia, affects many men after age 40. The gland, about the size of a walnut, is below the bladder and surrounds the urine-carrying canal or ...Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year
... Try Lifestyle Changes First; Then Drugs Almost all men -- if they reach a certain age -- will develop an enlarged prostate, also known as Benign prostatic Hypertrophy, or BPH. The statistics are not precise, but about half of men of any age who have BPH will have symptoms that require attention and ...For Men Over 50, Odds of Eye Discomfort Increases
... in Boston and colleagues noted in the June issue of the Archives of Ophthalmology . Among men, increasing age, high blood pressure, benign prostatic hyperplasia (a noncancerous enlargement of the prostate) and the use of antidepressants increase the chances of developing dry eye disease, the study ...... detection (colon cancer), a medication (the use of statins for treatment of elevated cholesterol) and a surgical procedure (treatment for benign prostatic hyperplasia). "The results of our study demonstrate that, while the lessons from the other countries' approaches to comparative effectiveness ...
New blood test greatly reduces false-positives in prostate cancer screening
... Oncology at Dana-Farber. The two-year study involved 484 participants. The group comprised 204 men with known prostate cancer, 110 men with benign prostatic hypertrophy (BPH), and 170 healthy men in a control group. (BPH can elevate PSA levels in the blood, which often leads to a biopsy to rule out ...Predicting higher risk for prostate cancer diagnosis
... High-grade prostatic intraepithelial neoplasia (HGPIN) carries a high predictive value for future diagnosis of prostate cancer. Research published in the open access ...... GELNIQUE, Watson recently launched RAPAFLO (TM) (silodosin), the Company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), which offers rapid relief and has an exceptional safety profile. The Company also has submitted a New Drug Application for its ...
Study Reiterates Eye Risks Linked to Flomax
... 100 had suspected inflammation within or around the eye. Flomax is often prescribed to treat an enlarged prostate, a condition known as benign prostatic hyperplasia, or BPH, which affects almost three of four men 70 and older. Symptoms include difficulty urinating. Flomax accounted for $1 billion in ...... detection (colon cancer), a medication (the use of statins for treatment of elevated cholesterol) and a surgical procedure (treatment for benign prostatic hyperplasia). "The results of our study demonstrate that, while the lessons from the other countries' approaches to comparative effectiveness ...
... the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available ...
... in a Phase 3 trial for metastatic colorectal cancer (MCRC). LSO has also completed a Phase 1/2 trial and has initiated a Phase 2a trial in benign prostatic hyperplasia (BPH), or enlargement of the prostate, and has clinical or preclinical programs in cardiovascular disease, eye disease, ...
Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
... 2 5-alpha reductase isoenzymes has not been established. Dutasteride is indicated for the treatment of moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It has been shown to improve urinary symptoms, reduce the risk of acute urinary retention (AUR), ...Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
... the launch of Rapaflo(TM) (silodosin), our new selective alpha-blocker that provides rapid and sustained relief of the signs and symptoms of benign prostatic hyperplasia (BPH)." "Based on our first quarter results and our view for the remainder of the year, we are raising our outlook for 2009, a clear ...... candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. ...
Data Show Dutasteride Reduces Prostate Cancer Diagnosis in Men With Increased Risk
... Annual Meeting, April 27 CHICAGO, April 28 /PRNewswire-USNewswire/ -- Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease, according to results of ...... UEBW (ultrasound-estimated bladder weight) and bladder volume quickly and noninvasively to help diagnose bladder dysfunction, including BPH (benign prostatic hypertrophy) and BOO (bladder outlet obstruction). This new addition to the BladderScan(R) BVI 9000 series made its official debut at the AUA 2009 ...
Prostate Study Shows BOTOX May Be Safe, Effective Method for Managing Benign Prostatic Hyperplasia
... different dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common noncancerous enlargement of the prostate that can cause difficulty in urination. "People often underestimate the ...Tadalafil may effectively treat symptoms of BPH-LUTS in addition to erectile dysfunction
... LINTHICUM, MD, April 26, 2009Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonia and Indianapolis will present these findings during the 104th Annual Scientific ...Harvard Medical School Prostate Disease Website Guides Patients Through Decision-Making Process
... to be well-informed." The new website provides multiple perspectives on how best to treat prostate disease, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis, as well as erectile dysfunction and low testosterone levels. "The public continues to be presented with ...Free Community Seminar; Reviews Treatment Options for Enlarged Prostate
... enlarged prostate will be the focus of a free community seminar on April 2, 2009 at 6:30pm at the Doubletree Hotel in Rosemead. Also known as benign prostatic hyperplasia (BPH), this non-cancerous enlargement of the prostate affects more than half of all men over the age of 60 and more than 26 million men ...Free Community Seminar to Review Treatment Options for Enlarged Prostate
... be the focus of a free community seminar on March 28, 2009 at 2:00pm at the Chestnut Hill Hospital Auditorium in Philadelphia. Also known as benign prostatic hyperplasia (BPH), this non-cancerous enlargement of the prostate affects more than half of all men over the age of 60 and more than 26 million men ...High Intensity Focused Ultrasound Physician Training Seminar in Mexico City
... Leading HIFU device in Mexico for Minimally Invasive Treatment for Prostate Cancer and Benign prostatic Hyperplasia draws attention from elite urologists CHARLOTTE, N.C., March 16 /PRNewswire/ -- Mexico HIFU in conjunction with International HIFU, ...Other ContentshistaminehistaminehistaminehiatalhistiocytosishistoplasmosishiccupsheterosexualheterosexualheterosexualOther TagsColonColonColonColonColonCompetentCompetitive
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How nutrition affects healthy aging 2Papillomavirus silences innate immune response 2Diplomat Specialty Pharmacy 3A Only Vendor to Receive URAC Accreditation for Both Disease Management and Drug Therapy Management 50990 1Diplomat Specialty Pharmacy 3A Only Vendor to Receive URAC Accreditation for Both Disease Management and Drug Therapy Management 50990 2Diplomat Specialty Pharmacy 3A Only Vendor to Receive URAC Accreditation for Both Disease Management and Drug Therapy Management 50990 3Neuroscience Researcher Has Positive Message for International Alzheimers Awareness Week July 6 12 3A Even Though World Economy is Declining Alzhe 4695 1Neuroscience Researcher Has Positive Message for International Alzheimers Awareness Week July 6 12 3A Even Though World Economy is Declining Alzhe 4695 2Cancer Gap Between Whites Blacks May Be Biological in Part 50988 1Cancer Gap Between Whites Blacks May Be Biological in Part 50988 2(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2[0] Never Married, Over 40, Well-Adjusted[0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] Free Health Clinic Event Is Not Just for the Sick
CofactorsColchicineCollectingColonCollenchymaColumellaColonyCommensalismCompatibleCompanionComparativeCompetentCompetitiveComplementary
Other Tagscomplicate 2refugees 2minute 2minute 3minute 4minute 5minute 6minute 7attached 2attached 3attached 4attached 5attached 6attached 7attached 8amphibians 2lethal 2lethal 3lethal 4lethal 5lethal 6lethal 7| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |